Edelman, a global communications and marketing company, has named Alan Maine as its new senior director, it was reported yesterday.
Maine has earlier served as head of policy and public affairs at Pfizer UK, where he was responsible for government affairs and market access policy development activity, covering both corporate and therapy area public affairs. During his time at Pfizer, Maine also worked with industry associations on campaigns, policies and initiatives relating to access to medicines. Prior to his time with Pfizer, Maine was head of government affairs at Wyeth Pharmaceuticals, later acquired by Pfizer, and has held other roles with Merck Sharpe & Dohme.
Kate Hawker, managing director for Edelman UK, said, 'We are very excited about Alan joining Edelman as he brings with him such great knowledge and insight of the complex challenges in the UK.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer